Lenskart outpaces Titan EyeCare on margins and growth in India's $9.2B eyewear race
Post-IPO Lenskart posted Q2 revenue of Rs 2,146.6 crore (up 24%), a 69.2% product margin and 19.8% EBITDA margin, adding 203 net new stores across 431 cities. Titan EyeCare drew higher footfall but saw profit slip, with segment EBIT at just Rs 12 crore on Rs 215 crore income.
What happened
Comparison of Lenskart and Titan EyeCare strategies and financials in India's ~$9.2 billion eyewear market. Lenskart posted 24% revenue growth and stronger
Key facts
- listed at Rs 390
- issue price Rs 402
- market $9.2 billion
- Rs 30,000 crore market
- 9.3 million eye tests H1
- 203 net new stores
- 431 cities
- Q2 product margin 69.2%
- Q2 revenue Rs 2,146.6 crore up 24%
- EBITDA Rs 425.8 crore 19.8% margin
- 871 Titan EyeCare stores
- Titan EyeCare income Rs 215 crore
- Titan segment EBIT Rs 12 crore
Why this matters
In India's $9.2B eyewear race, Lenskart's margin and expansion lead against Titan's footfall-heavy but low-profit segment highlights consolidation opportunities and defensive positioning for legacy players.
What to watch
- Lenskart same-store sales growth vs new-store contribution split in next quarter
- Titan EyeCare EBIT recovery or further slippage in Q3
- Lenskart EBITDA margin trend as store count scales (dilution signal)
- Post-IPO lock-up expiry and any insider selling pressure
- Competitive discounting or entry of D2C eyewear challengers
- Lenskart accelerates store rollout into tier-2/3 cities to lock share before Titan responds
- Titan restructures EyeCare pricing and pushes higher-margin lens/frame bundles to lift segment EBIT
- Both intensify omnichannel and private-label push; watch for discounting wars in mass segment
- Analysts revise Lenskart target multiples upward while flagging store-maturity risk